EXAM COMPLETE 350 QUESTIONS AND
DETAILED SOLUTIONS LATEST
UPDATE 2026
1. A 52-year-old woman reports 3 months of irregular periods followed by a 45-day interval without
menses and is now experiencing hot flashes and night sweats. According to the STRAW+10 system,
which stage is most consistent?
A) Early reproductive (−3b)
B) Late reproductive (−3a)
C) Early menopausal transition (−2)
D) Late menopausal transition (−1)
Correct Answer: C
Rationale: In the STRAW+10 staging system, the early menopausal transition (stage −2) is characterized
by persistent differences in cycle length of 7 or more days. The late transition (−1) is marked by 60 or
more days of amenorrhea. Here the patient has a 45-day interval with vasomotor symptoms, placing her in
the early transition.
2. A 49-year-old patient asks why her hot flashes have worsened over the past year. Which physiologic
change best explains this?
A) Progressive decline in progesterone only
B) Abrupt decline in both estradiol and inhibin B
C) Increase in FSH without change in estradiol
D) Androgen excess from theca cell stimulation
1
,Correct Answer: B
Rationale: As ovarian follicular reserve declines, estradiol and inhibin B levels decrease abruptly. This
withdrawal of estradiol from thermoregulatory centers in the hypothalamus triggers vasomotor symptoms.
The decline is not limited to progesterone or androgen changes alone.
3. What is the average age of natural menopause in women in the United States?
A) 45 years
B) 51 years
C) 55 years
D) 60 years
Correct Answer: B
Rationale: The average age of natural menopause in the United States is approximately 51 years, with
95% of women experiencing it between ages 45 and 55. This is a key demographic fact in menopause
physiology per NAMS guidelines.
4. Which hormone therapy regimen is recommended for a woman with an intact uterus experiencing
menopausal symptoms?
A) Estrogen alone
B) Estrogen plus progestogen
C) Progestogen alone
D) Testosterone plus estrogen
Correct Answer: B
Rationale: In women with an intact uterus, estrogen plus progestogen is required to protect the
endometrium from hyperplasia and reduce the risk of endometrial cancer associated with unopposed
estrogen.
2
,5. What is the most effective treatment for moderate to severe vasomotor symptoms?
A) Antidepressants like SSRIs
B) Systemic hormone therapy
C) Herbal supplements such as black cohosh
D) Acupuncture
Correct Answer: B
Rationale: Systemic estrogen-containing hormone therapy is the most effective treatment for vasomotor
symptoms, reducing frequency and severity by up to 75%.
6. A 48-year-old woman with a history of breast cancer (ER+) asks about nonhormonal options for severe
hot flashes. Which would be most appropriate?
A) Systemic estrogen therapy
B) Venlafaxine
C) Testosterone therapy
D) Progestin-only therapy
Correct Answer: B
Rationale: In breast cancer survivors, systemic hormone therapy is contraindicated. Venlafaxine, an
SNRI, is a first-line nonhormonal option for vasomotor symptom management in this population.
7. What is primary ovarian insufficiency (POI)?
A) Menopause after age 50
B) Menopause before age 40
C) Irregular cycles after age 45
3
, D) Cessation of ovulation after age 55
Correct Answer: B
Rationale: POI is defined as menopause occurring before age 40. Diagnosis requires oligomenorrhea or
amenorrhea for at least 4 months and FSH >25 IU/L on two occasions.
8. In women with primary ovarian insufficiency, until approximately what age is hormone therapy
recommended?
A) Age 40
B) Average age of natural menopause (~51)
C) Age 60
D) Indefinitely without reassessment
Correct Answer: B
Rationale: Hormone therapy is recommended until the average natural menopause age to mitigate long-
term risks of early estrogen deficiency.
9. What screening is recommended for bone health in postmenopausal women?
A) DEXA scan based on risk factors including age and history
B) Routine MRI of spine
C) Annual blood calcium only
D) No screening needed
Correct Answer: A
Rationale: DEXA scanning is recommended based on risk factors including age and history. Routine MRI
or annual calcium alone are insufficient for osteoporosis screening.
4